Skip to main content
Premium Trial:

Request an Annual Quote

Panvera Eyes European Expansion

TORONTO, June 11 - Panvera is looking to expand to Europe, a company official told GenomeWeb today.

 

President Mike Wokasch said Panvera hopes to have at least two people on the ground in Europe, possibly the UK, within a year to help the company sell its protein drug targets and its drug-screening essays, and also to provide tech support.

 

"Europe represents a significant growth opportunity for us," said Wokasch, who was tapped in March to run Vertex's other unit, Aurora Biosciences. He made his comments during lunch with a GenomeWeb reporter in between sessions at the BIO 2002 conference here, which ends tomorrow.

 

He said Madison, Wisc.-based Panvera is "debating" whether to hire locally or to plant a current US-based staffer.

 

Aurora, a San Diego-based biotech concern, acquired Panvera in March 2001. One month later Vertex gobbled up Aurora.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.